Blair William & Co. IL Purchases 3,555 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Blair William & Co. IL lifted its position in UnitedHealth Group Incorporated (NYSE:UNHFree Report) by 1.0% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 370,156 shares of the healthcare conglomerate’s stock after acquiring an additional 3,555 shares during the period. Blair William & Co. IL’s holdings in UnitedHealth Group were worth $186,629,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in UNH. Axiom Financial Strategies LLC acquired a new stake in UnitedHealth Group during the 1st quarter worth about $210,000. McGowan Group Asset Management Inc. boosted its stake in shares of UnitedHealth Group by 8.9% during the 1st quarter. McGowan Group Asset Management Inc. now owns 744 shares of the healthcare conglomerate’s stock worth $379,000 after acquiring an additional 61 shares in the last quarter. Mirae Asset Global Investments Co. Ltd. boosted its stake in shares of UnitedHealth Group by 31.8% during the 1st quarter. Mirae Asset Global Investments Co. Ltd. now owns 250,196 shares of the healthcare conglomerate’s stock worth $127,592,000 after acquiring an additional 60,300 shares in the last quarter. MAS Advisors LLC boosted its stake in shares of UnitedHealth Group by 10.8% during the 1st quarter. MAS Advisors LLC now owns 463 shares of the healthcare conglomerate’s stock worth $241,000 after acquiring an additional 45 shares in the last quarter. Finally, First Western Trust Bank purchased a new stake in shares of UnitedHealth Group during the 1st quarter worth about $875,000. 85.69% of the stock is owned by institutional investors and hedge funds.

Insider Transactions at UnitedHealth Group

In other news, Director Stephen J. Hemsley sold 66,081 shares of UnitedHealth Group stock in a transaction on Tuesday, December 5th. The shares were sold at an average price of $550.39, for a total transaction of $36,370,321.59. Following the completion of the sale, the director now directly owns 635,528 shares of the company’s stock, valued at approximately $349,788,255.92. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Corporate insiders own 0.35% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research analysts recently weighed in on the stock. HSBC reaffirmed a “reduce” rating and issued a $480.00 price target (down from $550.00) on shares of UnitedHealth Group in a research note on Monday, December 18th. Oppenheimer reaffirmed an “outperform” rating and issued a $610.00 price target on shares of UnitedHealth Group in a research note on Wednesday, January 17th. Morgan Stanley decreased their price target on shares of UnitedHealth Group from $587.00 to $579.00 and set an “overweight” rating on the stock in a research note on Monday, October 23rd. Stephens reissued an “overweight” rating and issued a $605.00 target price on shares of UnitedHealth Group in a research note on Thursday. Finally, Royal Bank of Canada reissued an “outperform” rating and issued a $596.00 target price on shares of UnitedHealth Group in a research note on Tuesday, January 16th. One research analyst has rated the stock with a sell rating, one has assigned a hold rating, thirteen have assigned a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $575.79.

Read Our Latest Stock Report on UnitedHealth Group

UnitedHealth Group Trading Down 0.6 %

UnitedHealth Group stock traded down $3.07 during trading on Friday, hitting $517.02. The company had a trading volume of 1,257,030 shares, compared to its average volume of 4,290,016. UnitedHealth Group Incorporated has a 1-year low of $445.68 and a 1-year high of $554.70. The company has a current ratio of 0.79, a quick ratio of 0.80 and a debt-to-equity ratio of 0.62. The company’s 50 day simple moving average is $525.94 and its 200-day simple moving average is $517.66. The stock has a market cap of $478.20 billion, a price-to-earnings ratio of 21.73, a price-to-earnings-growth ratio of 1.41 and a beta of 0.54.

UnitedHealth Group (NYSE:UNHGet Free Report) last issued its quarterly earnings results on Friday, January 12th. The healthcare conglomerate reported $6.16 EPS for the quarter, beating the consensus estimate of $5.98 by $0.18. UnitedHealth Group had a net margin of 6.02% and a return on equity of 26.39%. The company had revenue of $94.43 billion during the quarter, compared to analysts’ expectations of $92.13 billion. During the same quarter last year, the company posted $5.34 EPS. The firm’s revenue was up 14.1% compared to the same quarter last year. As a group, analysts expect that UnitedHealth Group Incorporated will post 27.84 EPS for the current fiscal year.

About UnitedHealth Group

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Featured Articles

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNHFree Report).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.